Seeing Beyond Retinopathy in Diabetes: Electrophysiological and Psychophysical Abnormalities and Alterations in Vision
Fiona M. E. Ewing1,
Ian J. Deary,
Mark W. J. Strachan2 and
Brian M. Frier
Department of Diabetes (F.M.E.E., M.W.J.S., B.M.F.), Royal
Infirmary of Edinburgh, Edinburgh EH3 9YW and Department of Psychology
(I.J.D.), University of Edinburgh, Edinburgh, EH8 9JZ Scotland United
Kingdom
I. Introduction
II. Electroretinography
A. Historical andtechnical aspects
B. ERG and diabetes
C. Type of diabetes
D. Duration of diabetes
E. Glycemic control
F. Age ofsubject
G. Retinopathy status
H. ERG and hypoglycemia
I.Summary
III. P100 Latency Studies
A. Historical and technicalaspects
B. P100 and diabetes
C. Type of diabetes
D. Durationof diabetes
E. Glycemic control
F. Age of subject
G. Retinopathystatus
H. Peripheral neuropathy
I. P100 and hypoglycemia
J. Summary
IV. P300 Studies
A. Historical and technicalaspects
B. P300 and diabetes
C. Type of diabetes
D. Glycemiccontrol and duration of diabetes
E. Retinopathy status
F.P300 and hypoglycemia
G. Summary
V. Color Vision
A. Historicaland technical aspects
B. Color vision and diabetes
C. Typeof diabetes
D. Duration of diabetes
E. Glycemic control
F. Age of subject
G. Retinopathy status
H. Color visionand hypoglycemia
I. Summary
VI. Contrast Sensitivity
A.Historical and technical aspects
B. Contrast sensitivity anddiabetes
C. Type of diabetes
D. Duration of diabetes
E.Glycemic control
F. Age of subject
G. Retinopathy status
H. Contrast sensitivity and hypoglycemia
I. Summary
VII.Conclusions
This article has been cited by other articles:
J. A. Phipps, J. L. Wilkinson-Berka, and E. L. Fletcher Retinal Dysfunction in Diabetic Ren-2 Rats Is Ameliorated by Treatment with Valsartan but Not Atenolol
Invest. Ophthalmol. Vis. Sci.,
February 1, 2007;
48(2):
927 - 934.
[Abstract][Full Text][PDF]
T. E. de Gooyer, K. A. Stevenson, P. Humphries, D. A. C. Simpson, T. A. Gardiner, and A. W. Stitt Retinopathy Is Reduced during Experimental Diabetes in a Mouse Model of Outer Retinal Degeneration
Invest. Ophthalmol. Vis. Sci.,
December 1, 2006;
47(12):
5561 - 5568.
[Abstract][Full Text][PDF]
D. J. Ramsey, H. Ripps, and H. Qian An Electrophysiological Study of Retinal Function in the Diabetic Female Rat
Invest. Ophthalmol. Vis. Sci.,
November 1, 2006;
47(11):
5116 - 5124.
[Abstract][Full Text][PDF]
M. J. Gastinger, R. S. J. Singh, and A. J. Barber Loss of Cholinergic and Dopaminergic Amacrine Cells in Streptozotocin-Diabetic Rat and Ins2Akita-Diabetic Mouse Retinas.
Invest. Ophthalmol. Vis. Sci.,
July 1, 2006;
47(7):
3143 - 3150.
[Abstract][Full Text][PDF]
Y. T. Elia, D. Daneman, J. Rovet, M. Abdolell, W.-C. Lam, C. Till, V. Erraguntla, S. Rubab, N. Lodha, and C. A. Westall Color Visual Evoked Potentials in Children with Type 1 Diabetes: Relationship to Metabolic Control
Invest. Ophthalmol. Vis. Sci.,
November 1, 2005;
46(11):
4107 - 4113.
[Abstract][Full Text][PDF]
M. A. Bearse Jr, Y. Han, M. E. Schneck, and A. J. Adams Retinal Function in Normal and Diabetic Eyes Mapped with the Slow Flash Multifocal Electroretinogram
Invest. Ophthalmol. Vis. Sci.,
January 1, 2004;
45(1):
296 - 304.
[Abstract][Full Text][PDF]